Shopping Cart
- Remove All
- Your shopping cart is currently empty
SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,720 | 3-6 months | |
50 mg | $4,680 | 3-6 months | |
100 mg | $6,200 | 3-6 months |
Description | SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes. |
Targets&IC50 | SGLT1/ SGLT2 (human):29nM/20 nM |
Molecular Weight | 669.85 |
Formula | C37H55N3O8 |
Cas No. | 1240305-17-2 |
Relative Density. | 1.182 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.